A clear focus on CNS and Hospital Injectables

Ethypharm is a specialty pharmaceutical company committed to providing products targeting the central nervous system (CNS) for patients who are suffering severe pain or opioid dependency as well as providing a wide range of high quality injectable medicines for use in hospital and emergency situations.

We use our considerable expertise and know-how to provide innovative solutions to healthcare providers and their patients.

In the UK we are recognised as a key partner of the NHS and the private hospital sector with a range of quality products most of which are manufactured at our UK facilities in Romford.

A commitment to the patients we serve

Many of our products are for patients who are either suffering from debilitating conditions such as pain or addiction or those who are in a critical state. Around the world, Ethypharm’s employees are working hard to make a difference to patients’ lives by endeavouring to help people in need so that they are able to receive the right medicines at the right time and with the right support.

A resilient company

The COVID-19 pandemic has put significant pressure on the pharmaceutical industry.

At Ethypharm, this crisis has highlighted the major role of our hospital injectable products which have been in high demand in intensive care units (ICUs) as well as the importance of our CNS products which have been used to treat mental health and opioid dependencies

The Ethypharm UK teams have put in tremendous efforts since the pandemic outbreak to ensure the continuous supply of our medicines to all our customers.

A solid and growing presence in our core territories

Since 2015, Ethypharm has built, and is now rapidly expanding, its presence in Europe and China.

Europe, where we currently have five affiliates (covering the United Kingdom, Germany, France, Italy and Spain) that accounts for half of the Group’s net sales. We are actively working to increase our presence in other EU countries.

Ethypharm is one of the few European specialty pharmaceutical companies to have had a longstanding presence in China. Through partnerships we introduce new medicines to patients in China that are already registered in other countries.

In the rest of the world, we work with our commercial partners to establish and increase the penetration of our product portfolio.

Ethypharm UK key figures (2021)

530+
UK employees

300+
employees work at our Romford facility

60
million sterile ampoules are produced per year

3
million bottles of oral solutions are produced per year

Ethypharm Group key figures (2021)

359 M€

Group net sales

of which

67%

in CNS and Hospital Injectables

6
direct countries

67%
of direct revenues

6
manufacturing sites

~1500
employees in the Group

We are building a sound and sustainable company

Based on ethical values and sustainability, Ethypharm listens to its stakeholders and communities. We strive to always act in compliance with regulations and integrity, transparency, diligence and respect on a daily basis which are fundamental values of Ethypharm. All of our employees are committed to these values. This commitment ensures the trust and recognition of our partners and patients with regards to our company and our products. It also contributes to the protection of each of us as employees as well as to Ethypharm’s reputation and interests.

Login

Request access

Warning

Are you a healthcare professional?

Reporting an Adverse Event